Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | CA12 | O43570 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA7 | P43166 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.36 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | FASN | P49327 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MLYCD | O95822 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL480464 | 0.93 | ESR1 (0.51) | ESR1ESR2CA2CA12CA1 | |
| SCHEMBL10067694 | 0.92 | ESR1 (0.45) | ESR1ESR2CA2CA12CA1 | |
| SCHEMBL18435199 | 0.85 | ESR1 (0.44) | ESR1ESR2CA2CA12CA1 | |
| SCHEMBL4418991 | 0.83 | ELANE (0.37) | ESR1ESR2CA2CA12CA1 | |
| SCHEMBL4418465 | 0.81 | MLYCD (0.36) | ESR1ESR2CA2ELANEFASN | |
| SCHEMBL4415869 | 0.81 | ELANE (0.38) | ESR1ESR2CA2CA12CA1 | |
| SCHEMBL3088741 | 0.80 | SRC (0.37) | ESR1ESR2CA2ELANEMLYCD | |
| Methoxymethane SCHEMBL4418025 | 0.78 | SRC (0.36) | ESR1ESR2CA2ELANEMLYCD | |
| SCHEMBL15648878 | 0.77 | ESR1 (0.42) | ESR1ESR2NPC1RAB9AALDH1A1 | |
| SCHEMBL4425744 | 0.77 | MLYCD (0.37) | CA2CA12CA1CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2411359-B1 | NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS | BASF SE (DE) | 2017-02-01 | — | — | EP | disclosed |
| US-20120029107-A1 | NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS | BASF SE (DE) | 2012-02-02 | — | — | US | disclosed |
| US-20120029107-A1 | NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS | BASF SE (DE) | 2012-02-02 | — | — | US | disclosed |
| WO-2010108862-A1 | NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS | BASF SE (DE) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029107-A1 | NOVEL OLIGOFUNCTIONAL PHOTOINITIATORS | CCNA1, CCNT1, TET1 | ESR1 822/4885ESR2 2609/4885CA2 4163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.